文献速递肝病

TRIB3-TRIM8复合物通过调控HNF4α稳定性驱动非酒精性脂肪性肝病进展

TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
PubMed 文献 · J Hepatol · 2024-01-17

本研究探讨内质网应激传感器TRIB3如何介导HNF4α降解及其在非酒精性脂肪性肝病(NAFLD)中的作用。TRIB3招募TRIM8形成E3泛素连接酶复合物,催化HNF4α第470位赖氨酸K48连接的多泛素化,促进其降解;用细胞穿透肽阻断TRIB3-HNF4α相互作用可恢复HNF4α水平并改善小鼠NAFLD进展。

要点

  • TRIB3直接结合HNF4α并介导内质网应激诱导的HNF4α降解。
  • TRIB3招募TRIM8形成E3连接酶复合物,催化HNF4α K470位K48多泛素化。
  • 细胞穿透肽阻断TRIB3-HNF4α相互作用可恢复HNF4α水平并改善小鼠NAFLD。

核心结论

  • TRIB3-TRIM8 E3连接酶复合物介导NAFLD中HNF4α降解,靶向该复合物介导的HNF4α多泛素化可能是NAFLD治疗的理想策略。
  • 干扰TRIM8-TRIB3-HNF4α相互作用可能为治疗NAFLD乃至其他肝病提供通过稳定HNF4α蛋白的新途径。

研究设计与样本

  • 在人和小鼠NAFLD组织中评估HNF4α与TRIB3的相关性。
  • 采用RNA测序、质谱分析、免疫共沉淀、体内和体外泛素化实验阐明TRIB3介导HNF4α降解的机制。
  • 通过分子对接和免疫共沉淀分析鉴定可阻断TRIB3-HNF4α相互作用的细胞穿透肽。

主要发现

  • TRIB3直接与HNF4α相互作用并介导内质网应激诱导的HNF4α降解。
  • TRIB3招募TRIM8形成E3连接酶复合物,催化HNF4α第470位赖氨酸K48连接的多泛素化。
  • 阻断HNF4α降解减弱了TRIB3在饮食诱导NAFLD模型中的作用。
  • TRIB3功能获得性变异p.Q84R与患者NAFLD进展相关,并在小鼠中诱导较低HNF4α水平和更严重肝脂肪变性。
  • 用细胞穿透肽破坏TRIB3-HNF4α相互作用可恢复小鼠HNF4α水平并改善NAFLD进展。

临床怎么用

  • 作者认为靶向TRIB3-TRIM8 E3复合物介导的HNF4α多泛素化可能是NAFLD治疗的理想策略。
  • 作者认为干扰TRIM8-TRIB3-HNF4α相互作用可能为治疗NAFLD乃至其他肝病提供通过稳定HNF4α蛋白的新途径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoplasmic reticulum (ER) stress of hepatocytes plays a causative role in non-alcoholic fatty liver disease (NAFLD). Reduced expression of hepatic nuclear factor 4α (HNF4α) is a critical event in the pathogenesis of NAFLD and other liver diseases. Whether ER stress regulates HNF4α expression remains unknown. The aim of this study was to delineate the machinery of HNF4α protein degradation and explore a therapeutic strategy based on protecting HNF4α stability during NAFLD progression. METHODS: Correlation of HNF4α and tribbles homologue 3 (TRIB3), an ER stress sensor, was evaluated in human and mouse NAFLD tissues. RNA-sequencing, mass spectrometry analysis, co-immunoprecipitation, in vivo and in vitro ubiquitination assays were used to elucidate the mechanisms of TRIB3-mediated HNF4α degradation. Molecular docking and co-immunoprecipitation analyses were performed to identify a cell-penetrating peptide that ablates the TRIB3-HNF4α interaction. RESULTS: TRIB3 directly interacts with HNF4α and mediates ER stress-induced HNF4α degradation. TRIB3 recruits tripartite motif containing 8 (TRIM8) to form an E3 ligase complex that catalyzes K48-linked polyubiquitination of HNF4α on lysine 470. Abrogating the degradation of HNF4α attenuated the effect of TRIB3 on a diet-induced NAFLD model. Moreover, the TRIB3 gain-of-function variant p.Q84R is associated with NAFLD progression in patients, and induces lower HNF4α levels and more severe hepatic steatosis in mice. Importantly, disrupting the TRIB3-HNF4α interaction using a cell-penetrating peptide restores HNF4α levels and ameliorates NAFLD progression in mice. CONCLUSIONS: Our findings unravel the machinery of HNF4α protein degradation and indicate that targeting TRIB3-TRIM8 E3 complex-mediated HNF4α polyubiquitination may be an ideal strategy for NAFLD therapy. IMPACT AND IMPLICATIONS: Reduced expression of hepatic nuclear factor 4α (HNF4α) is a critical event in the pathogenesis of NAFLD and other liver diseases. However, the mechanism of HNF4α protein degradation remains unknown. Herein, we reveal that TRIB3-TRIM8 E3 ligase complex is responsible for HNF4α degradation during NAFLD. Inhibiting the TRIB3-HNF4α interaction effectively stabilized HNF4α protein levels and transcription factor activity in the liver and ameliorated TRIB3-mediated NAFLD progression. Our findings demonstrate that disturbing the TRIM8-TRIB3-HNF4α interaction may provide a novel approach to treat NAFLD and even other liver diseases by stabilizing the HNF4α protein.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Xiao MC, Jiang N, Chen LL, et al. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability. J Hepatol. 2024. PMID: 38237865. doi:10.1016/j.jhep.2023.12.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。